Genomictree Inc. (KOSDAQ:228760)
South Korea
· Delayed Price · Currency is KRW 15,720
+500 (3.29%)
Apr 1, 2025, 3:30 PM KST
Genomictree Revenue
In the year 2024, Genomictree had annual revenue of 2.36B KRW, down -30.89%. Genomictree had revenue of 824.47M in the quarter ending December 31, 2024, with 24.59% growth.
Revenue
2.36B
Revenue Growth
-30.89%
P/S Ratio
158.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
377.12B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |